• Profile
Close

Platelet rich plasma injection for acute Achilles tendon rupture: PATH-2 randomized, placebo controlled, superiority trial

BMJ Nov 27, 2019

Keene DJ, Alsousou J, Harrison P, et al. - In this randomized, placebo-controlled, two-arm, parallel-group, participant and assessor masked, superiority trial done at secondary care trauma units across 19 hospitals in the United Kingdom’s health service of 230 adults aged 18 years and over with acute Achilles tendon rupture presenting within 12 days of injury and managed with non-surgical treatment, experts intended to ascertain whether an injection of platelet-rich plasma enhanced outcomes following acute Achilles tendon rupture. Individuals were randomly allocated to platelet-rich plasma (n = 114) or placebo (dry needle; n = 116) injection group. No evidence to designated that injections of platelet-rich plasma could enhance objective muscle-tendon function, patient-reported function, or quality of life following acute Achilles tendon rupture in comparison with placebo, or that they propose any patient advantage, was noted.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay